1. Analysis of Somatostatin Receptor 2A Immunohistochemistry, RT-qPCR, and In Vivo PET/CT Data in Patients With Pancreatic Neuroendocrine Neoplasm. Issue 4 (May 2015) Authors: Kaemmerer, Daniel; Wirtz, Ralph M.; Fischer, Elke K.; Hommann, Merten; Sänger, Jörg; Prasad, Vikas; Specht, Elisa; Baum, Richard P.; Schulz, Stefan; Lupp, Amelie Journal: Pancreas Issue: Volume 44:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma. (May 2022) Authors: Klümper, Niklas; Sikic, Danijel; Saal, Jonas; Büttner, Thomas; Goldschmidt, Franziska; Jarczyk, Jonas; Becker, Philippe; Zeuschner, Philip; Weinke, Maximilian; Kalogirou, Charis; Breyer, Johannes; Burger, Maximilian; Nuhn, Philipp; Tully, Karl; Roghmann, Florian; Bolenz, Christian; Zengerling, Fr... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy. (21st September 2018) Authors: Tsiatas, Marinos; Kalogeras, Konstantine T.; Manousou, Kyriaki; Wirtz, Ralph M.; Gogas, Helen; Veltrup, Elke; Zagouri, Flora; Lazaridis, Georgios; Koutras, Angelos; Christodoulou, Christos; Pentheroudakis, George; Petraki, Constantina; Bafaloukos, Dimitrios; Pectasides, Dimitrios; Kosmidis, Paris... Journal: Cancer medicine Issue: Volume 7:Number 10(2018:Oct.) Page Start: 5066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non‐muscle‐invasive bladder cancer. (9th September 2018) Authors: Breyer, Johannes; Wirtz, Ralph M.; Erben, Philipp; Rinaldetti, Sebastien; Worst, Thomas S.; Stoehr, Robert; Eckstein, Markus; Sikic, Danijel; Denzinger, Stefan; Burger, Maximilian; Hartmann, Arndt; Otto, Wolfgang Journal: BJU international Issue: Volume 123:Number 1(2019) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MiRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Issue 9 (September 2015) Authors: Benderska, Natalya; Dittrich, Anna-Lena; Knaup, Sabine; Rau, Tilman T.; Neufert, Clemens; Wach, Sven; Fahlbusch, Fabian B.; Rauh, Manfred; Wirtz, Ralph M.; Agaimy, Abbas; Srinivasan, Swetha; Mahadevan, Vijayalakshmi; Rümmele, Petra; Rapti, Emmanouela; Gazouli, Maria; Hartmann, Arndt; Schneider-St... Journal: Inflammatory bowel diseases Issue: Volume 21:Issue 9(2015:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer. (1st November 2009) Authors: Fountzilas, George; Kalogera-Fountzila, Anna; Lambaki, Sophia; Wirtz, Ralph M.; Nikolaou, Angelos; Karayannopoulou, Georgia; Bobos, Mattheos; Kotoula, Vassiliki; Murray, Samuel; Lambropoulos, Alexandros; Aravantinos, Gerasimos; Markou, Konstantinos; Athanassiou, Eleni; Misailidou, Despina; Kaloge... Other Names: Psyrri Amanda Academic Editor. Journal: Journal of oncology Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer. (1st November 2009) Authors: Fountzilas, George; Kalogera-Fountzila, Anna; Lambaki, Sophia; Wirtz, Ralph M.; Nikolaou, Angelos; Karayannopoulou, Georgia; Bobos, Mattheos; Kotoula, Vassiliki; Murray, Samuel; Lambropoulos, Alexandros; Aravantinos, Gerasimos; Markou, Konstantinos; Athanassiou, Eleni; Misailidou, Despina; Kaloge... Other Names: Psyrri Amanda Academic Editor. Journal: Journal of oncology Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. (January 2019) Authors: Eckstein, Markus; Erben, Philipp; Kriegmair, Maximilian C.; Worst, Thomas S.; Weiß, Cleo-Aron; Wirtz, Ralph M.; Wach, Sven; Stoehr, Robert; Sikic, Danijel; Geppert, Carol I.; Weyerer, Veronika; Bertz, Simone; Breyer, Johannes; Otto, Wolfgang; Keck, Bastian; Burger, Maximilian; Taubert, Helge; Wei... Journal: European journal of cancer Issue: Volume 106(2019) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma. Issue 3 (26th August 2021) Authors: Kendre, Gajanan; Marhenke, Silke; Lorz, Georgina; Becker, Diana; Reineke‐Plaaß, Tanja; Poth, Tanja; Murugesan, Karthikeyan; Kühnel, Florian; Woller, Norman; Wirtz, Ralph M.; Pich, Andreas; Marquardt, Jens U.; Saborowski, Michael; Vogel, Arndt; Saborowski, Anna Journal: Hepatology Issue: Volume 74:Issue 3(2021) Page Start: 1357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗